UNILEVER PLC UL
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS—
Annual financial statements
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000217410-26-000007.
Others in SIC 2840
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| PG | PROCTER & GAMBLE Co | $340.39B | 22.1x | 3.3% |
| ECL | ECOLAB INC. | $78.29B | 38.4x | 2.2% |
| CHD | CHURCH & DWIGHT CO INC /DE/ | $23.38B | 32.6x | 1.6% |
| SCL | STEPAN CO | $1.44B | 30.9x | 7.0% |
| WNW | Meiwu Technology Co Ltd | — | — | 4,368.0% |
| BYAH | Park Ha Biological Technology Co., Ltd. | — | — | 6.0% |